1-2 of 2
Sylvia Bellucci, MD,PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Complete Hematological, Molecular and Histological Remissions without Cytoreductive Treatment Lasting After Pegylated-Interferon α-2a (peg-IFNα-2a) Therapy in Polycythemia Vera (PV): Long Term Results of a Phase 2 Trial

Pascal Turlure, MD, Nathalie Cambier, MD, Murielle Roussel, Sylvia Bellucci, MD, PhD, Jean-Marc Zini, MD, PhD, Jean-Didier Rain, MD, Philippe Rousselot, MD, PhD, William Vainchenker, MD, PhD, Lina Abdelkader, Kamel Ghomari, Jean-Luc Dutel, Yasmine Chait, Sylvie Chevret, Christine Chomienne, MD, PhD, Bruno Cassinat, PharmD, Jean-Jacques Kiladjian, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 280.
https://doi.org/10.1182/blood.V118.21.280.280
Published: 2011
Journal Articles

Peg IFNα-2a in Polycythemia Vera (PV). Results of a Phase 2 Study by the French “PV-NORD” Group.

Jean-Jacques Kiladjian, MD, Bruno Cassinat, MD, Pascal Turlure, MD, Nathalie Cambier, MD, Sylvia Bellucci, MD,PhD, Murielle Roussel, MD, Marie-José Grange, MD, Bernard Grandchamp, MD,PhD, Jean-Didier Rain, MD,PhD, Christine Chomienne, MD,PhD, Pierre Fenaux, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 670.
https://doi.org/10.1182/blood.V108.11.670.670
Published: 2006